Blaze Bioscience, Inc. — Form D/A

Blaze Bioscience, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2020-04-08. The offering totals $25.2M, of which $20.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Heather FranklinDirectorSeattle, WA
Mary Ellen HughesDirectorSeattle, WA
Jan Koch OhrstromDirectorSeattle, WA
James Cameron TowneDirectorSeattle, WA
Heather FranklinExecutive OfficerSeattle, WA
Claudia Koch JochheimExecutive OfficerSeattle, WA
Ludmila Cameron LobanovaExecutive OfficerSeattle, WA
Dennis Cameron MillerExecutive OfficerSeattle, WA
Heather L FranklinDirectorSeattle, WA
Steven R DalyDirectorSeattle, WA
Steven R DalyExecutive OfficerSeattle, WA
Lawrence Patrick HughesDirectorSeattle, WA
James C TowneDirectorSeattle, WA
James C TowneExecutive OfficerSeattle, WA
Ludmila R LobanovaExecutive OfficerSeattle, WA
Jan K OhrstromDirectorSeattle, WA
James OlsonDirectorSt. Petersburg, FL
JAN ELLEN OHRSTROMDirectorSEATTLE, WA
CLAUDIA ELLEN JOCHHEIMExecutive OfficerSEATTLE, WA
DENNIS C MILLERExecutive OfficerSEATTLE, WA
LUDMILA C LOBANOVAExecutive OfficerSEATTLE, WA
Julia NovakExecutive OfficerSeattle, WA
Dennis MillerExecutive OfficerSeattle, WA
Ludmila LobanovaExecutive OfficerSeattle, WA
James TowneDirectorSeattle, WA

Other filings by this issuer (14)

FiledFormOfferingSold
2024-10-21D$20.0M$8.1M
2024-10-21D$25.0M$25.0M
2024-10-21D$15.0M$15.0M
2024-10-21D$10.0M$10.0M
2019-02-14D$20.2M$5.0M
2018-05-15D$5.0M$3.0M
2017-10-10D$18.1M$16.1M
2017-06-22D$5.0M$554K
2016-01-12D$5.0M$991K
2015-06-25D/A$15.0M$9.7M
2014-06-26D/A$15.0M$9.6M
2013-06-27D$15.0M$8.1M
2012-06-19D$10.7M$6.4M
2011-10-17D$1.5M$725K

More